SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLASs anticipated Phase 3 REGAL topline results for its GPS leukemia treatment, a binary catalyst that has traders weighing hopes for a positive readout against concerns about trial failure. The debate is intensified by sharp price swings, with bullish claims of short pressure and manipulation contested by skeptics who see the outcome as uncertain.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported preliminary takeover discussions involving Silver Lake and Saudi Arabias PIF are fueling attention, though traders debate whether the valuation discussed is too low and whether a deal will happen. The speculation comes alongside Unitys strong Q3 results, first GAAP-profitable quarter, and rapid Vector ad growth, which some traders argue support the companys standalone value.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians persistent share-price weakness and choppy trading dominate discussion, with traders attributing pressure to short-selling or options activityclaims that remain speculative. Bulls point to Q3 progress, R2 recognition and the upcoming Autonomy & AI Day, while skeptics focus on cash burn, profitability and management execution.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is in focus ahead of the FDAs PDUFA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders are split: bulls point to strong progression-free-survival results, improving survival trends and AstraZenecas backing, while bears emphasize that the trial missed statistical significance for overall survival and the FDA indicated that evidence was needed.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp, high-volume move has revived speculation about a Big Pharma partnership or buyout for Vikings obesity-drug pipeline, particularly VK2735, alongside attention to its ObesityWeek presentations. Traders disagree on whether the activity signals genuine strategic interest or is another rumor-fueled trading surge; no deal is confirmed.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure has put Nvidias leadership succession in focus, with reports that the board approached Arm CEO Rene Haas and speculation among traders that Huang could return. The community is split between buyers who see Nvidias AI-chip business and upcoming results as resilient and skeptics concerned about succession uncertainty, governance scrutiny, and possible fallout from export investigations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is under pressure after its outlook raised concerns about delayed third-party data-center capacity and revenue timing, with analyst downgrades and weakness across AI infrastructure stocks adding to the selloff. Traders are divided between expecting further losses and viewing the decline as an overreaction and a buying opportunity.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

A quarterly earnings beat and higher full-year outlook, supported by strong demand for the Wegovy pill, are fueling renewed interest in Novo Nordisk. Bulls see evidence of a recovery, while skeptics point to diabetes weakness, pricing pressure and competition from Eli Lilly as reasons to question whether the turnaround will last.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is drawing attention over the squeeze from elevated jet-fuel costs, linked by traders to oil-market disruption and the Iran conflict, with recent earnings discussion highlighting that strong revenue has not translated into profits and the outlook has weakened. Bears worry about prolonged fuel pressure and AALs debt, while bulls see room for recovery if oil prices ease and travel demand remains firm.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

HAWK is drawing attention after reporting record third-quarter revenue and raising its full-year outlook, with traders also highlighting the earnings-call discussion of international growth, cash reserves and lower-cost satellites. The reaction is broadly bullish amid a sharp, high-volume rise, though claims of institutional accumulation remain speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HELE Stock On Track For Best Day In Over 25 Years After Rejecting $37 Per Share Takeover Bid

Equity

Helen of Troy said its board determined the proposal from Empower Brands Holdings Group “substantially undervalues” the company.


CRMD Stock Hits Fresh 52-Week Low On DaVita’s Warning Of Sharp 2027 DefenCath Reimbursement Drop

DefenCath is CorMedix’s largest revenue driver in the dialysis setting, generating $258.8 million in net sales in 2025 and accounting for a majority of the company's reported full-year revenue of $311.7 million. 

Macy’s Raises Full Year Outlook After Strong Q2 — Says Inventories ‘Well-Positioned’ Heading Into Second Half Of 2026

Macy’s raised its fiscal 2026 outlook after comparable sales grew across all three nameplates, led by record second-quarter sales volume at Bloomingdale’s.

American Eagle Drops Big Ad Campaigns, Chases the Checkout 

American Eagle posted a quarterly profit beat that leaned on a $161 million tariff refund on Wednesday. 


LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Bloomberg reported that Curium is discussing a deal that would pay roughly $102 per Lantheus share in cash upfront plus an additional $12.50 per share in contingent value rights. 


QTTB Stock Clocks Best Day In A Year Following Positive Alopecia Data — Analyst Sees Further 200% Upside

Patients treated with bempikibart for 36 weeks saw a 35% average reduction in scalp hair loss severity, the company said. 

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

QuidelOrtho is in talks to sell its point-of-care testing unit behind the rapid antigen tests for Covid and flu, Financial Times reported over the weekend. 


No Fed Rate Cut in 2026? ETFs to Gain 

Nomura joins Wall Street firms expecting no Fed rate cuts in 2026. These value, bank and cash-flow ETFs could benefit.

IMAX Stock Soars After Hours Following News Of Early-Stage Sale Process

According to a Wall Street Journal report, IMAX has begun gauging interest from possible buyers, including major entertainment companies. 


CARS Stock Rallies After-Hours On 11% Layoff, Increased Buyback Plans

The company said that the layoffs, in addition to process changes and vendor cost optimization, is expected to generate $25-30 million in recurring annualized operating cost savings in 2027. 


American Century ETF Trust - Avantis U.S. Small Cap Value ETF

Neutral Sentiment

<ul class="summary-bullets"><li>The company’s board argued that continuing to execute its multi-year strategic plan would create greater long-term value than accepting the “opportunistic” bid.</li><li>The board pointed to progress under CEO G. Scott Uzzell, who was appointed in September 2025.</li><li>Empower Brands, meanwhile, has framed its offer as providing immediate cash certainty at a premium to recent trading levels, with no financing contingency.</li></ul><p>Shares of Helen of Troy Limited (HELE) jumped as much as 27% on Wednesday after the consumer products company confirmed it had unanimously rejected an unsolicited $37-per-share all-cash takeover proposal.</p><p>The stock climbed from a prior close near $29.54 to trade around $37, putting it on track for its best day since July 2001, if the gains hold.</p><p>Helen of Troy, a global consumer products company that owns or licenses brands including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive &amp; June, said its board determined the proposal from Empower Brands Holdings Group “substantially undervalues” the company. Empower Brands is owned by Spectrum Brands and Oaktree Capital Management. The board argued that continuing to execute its multi-year strategic plan would create greater long-term value than accepting the “opportunistic” bid.</p><h2 class="st-heading-2">Helen’s Rationale For Rejecting Bid</h2><p>Helen of Troy said the board, after reviewing the proposal with financial and legal advisers, concluded it was not in the best interests of the company or its shareholders. The firm noted that Empower Brands first submitted a $34-per-share proposal in August 2026, which was rejected, then raised the offer to $37 in October. The company said Empower Brands declined to enter a standard non-disclosure agreement that would have allowed further diligence, which Helen of Troy characterized as underscoring the opportunistic nature of the approach. The proposal came amid a period of stock-price dislocation linked in part to tariff-related disruption, the company added.</p><p>The board pointed to progress under CEO G. Scott Uzzell, who was appointed in September 2025. Helen of Troy recently reported strong second-quarter fiscal 2027 results, raised guidance, and is reinvesting $66.5 million to $70.5 million of tariff refunds into the business, it noted. The company outlined a three-phase roadmap in April that targets low-to-mid-single-digit sales growth, high-single-digit adjusted core profit growth, mid-to-high-teens adjusted earnings per share growth, and free cash flow conversion approaching 75% by year five of the plan.</p><p>“The Board remains open to opportunities that are in the best interest of Helen of Troy and its shareholders and will appropriately consider opportunities consistent with its fiduciary duties,” the company said.</p><h2 class="st-heading-2">Empower’s Rationale</h2><p>Empower Brands, meanwhile, has framed its offer as providing immediate cash certainty at a premium to recent trading levels, with no financing contingency.</p><p>“We believe our all-cash proposal offers Helen of Troy’s shareholders compelling and certain value at an attractive premium. As Helen of Troy is currently comprised, it does not have the scale or the financial ability to acquire or achieve the scale to compete in a landscape that we know well,” Spectrum Brands CEO David Maura said. The firm also highlighted the near 87% decline in HELE's share price over the past five years, the company's repeated earnings disappointments, and its changing leadership, with three CEOs in the past three years.</p><h2 class="st-heading-2">How Did HELE Retail Traders React?</h2><p>On Stocktwits, retail sentiment around <a class="mention" data-mention="$HELE" data-symbol-id="HELE" href="https://stocktwits.com/symbol/HELE" target="_blank">HELE stock</a> jumped from 'neutral' to 'extremely bullish' territory over the past 24 hours, while message volume jumped from 'extremely low' to 'high' levels.</p><p>A Stocktwits user noted that the shares are undervalued and have significant potential upside.</p><p><stembedurl>https://stocktwits.com/MuneeMakr/message/668122836</stembedurl></p><p>HELE stock has gained 73% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/vst-ceg-stocks-drop-as-election-outcome-hits-merchant-power-generators/cNGLkduR93x">VST, CEG Stocks Drop As Election Outcome Hits Merchant Power Generators</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

In this photo illustration, the Helen of Troy Limited logo is seen displayed on a smartphone screen

Helen of Troy said its board determined the proposal from Empower Brands Holdings Group “substantially undervalues” the company.

Helen of Troy Ltd

Vanguard Total Stock Market ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

AVUV News